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Summary
Introduction:  This  pilot  series  sought  to  assess  the  use  of  external  ultrasound  stimulation
(ExogenTM)  in  the  treatment  of  femoral  or  tibial  non-union.
Materials  and  methods:  A  continuous  retrospective  study  was  conducted  from  2004  to  2009.  It
included patients  with  a  non-united  fracture  or  osteotomy  at  6  months  or  more  post-surgery,
with less  than  10  mm  inter-fragment  gap.  Daily  20-min  ultrasound  sessions  were  continued  until
bone healing  was  achieved  or  for  a  maximum  6-month  duration.  Radio-clinical  control  was
performed at  months  3  and  6;  treatment  compliance  and  transmitter  positioning  were  checked
at each  follow-up  visit.
Results:  Sixty  non-unions  were  included  in  the  series.  One  patient  was  excluded  for  early  mate-
rial breakage.  Mean  fracture-to-surgery  interval  was  271  days.  The  6-month  consolidation  rate
was 88%.  There  was  no  loss  to  follow-up.  Mean  ultrasound  treatment  duration  was  151  days
(range, 90—240  days).  Bone  healing  correlated  signiﬁcantly  with  stability  of  the  internal  ﬁxa-
tion assembly  (P  =  0.01).  The  seven  cases  of  failure  included  four  ﬁxations,considered  unstable
at inclusion,  one  femoral  non-union  associated  with  BMI  45  and  one  inadequate  subchondral
roughening  (at  the  time  of  arthrodesis).  There  was  a  signiﬁcant  difference  in  delay  to  non-union
treatment  start  between  the  groups  with  (251  days)  and  without  (420  days)  bone  healing.
Discussion:  The  present  results  are  in  line  with  the  literature.  The  main  prognostic  factors  were
fracture ﬁxation  stability,  short  time  to  treatment,  and  inter-fragment  gap  less  than  10  mm.
Bone healing  rates  in  the  literature  are  around  80%  for  non-union  treated  at  around  6  months,
versus 60%  for  more  than  12  months’  delay.  Factors  such  as  gender,  bone  site,  smoking,  numbers
of previous  operations  or  type  of  osteosynthesis  do  not  impact  consolidation.  External  treat-
ment offers  an  alternative  to  traditional  surgery  (graft,  or  bone-marrow  concentrate  or  bone
morphogenetic  protein  injection),  provided  that  the  fracture  ﬁxation  is  stable.  Bone  healing
rates are  better,  and  the  procedure  is  non-invasive.  External  treatment  results  using  ultrasound
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are  similar  to  those  using  electromagnetic  ﬁelds;  the  main  difference  lies  in  treatment  session
duration,  which  is  20  min  for  ultrasound,  versus  3  hours  for  electromagnetic  ﬁelds.  Active  patient
commitment  is  vital,  as  the  treatment  is  delivered  at  home,  although  the  machine  is  equipped
with a  monitor  to  count  treatment  cycles.
Conclusion:  The  88%  bone  healing  rate  supports  advocating  ﬁrst-line  implementation  in  non-
union of  less  than  10  mm  with  stable  osteosynthesis.  This  rate  is  higher  than  in  traditional
surgery, with  a  unit  cost  at  least  60%  lower:  D  1772  for  external  therapy,  versus  D  4480  for
decortication  with  or  without  fracture  ﬁxation  exchange  (itemized  08c50  under  the  French
healthcare  treatment  coding  system).
Level  of  evidence:  Level  IV.  Retrospective  therapeutic  study.
© 2012  Published  by  Elsevier  Masson  SAS.
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rotational)  and  radiologically  as  absence  of  mobility  cham-
ber  in  the  osteosynthesis  material  (Fig.  1).
The  interval  between  trauma  and  initiation  of  external
stimulation  was  recorded,  as  were  the  number  of  previous
surgical  operations  for  delayed  consolidation.Introduction
External  stimulation  is  currently  being  developed  for  the
treatment  of  non-union.  In  France,  there  are  no  database
(whether  under  the  Health  Authority  or  by  the  National
health  insurance  agency)  enabling  how  widespread  their  use
is  to  be  judged.  From  the  literature  [1],  however,  and  manu-
facturers’  sales  ﬁgures,  it  can  be  estimated  that  the  number
of  patients  rose  from  22  in  2004  to  more  than  1000  in  2010.  In
France,  two  devices  are  available:  PhysioStimTM (using  elec-
tromagnetic  ﬁelds)  and  ExogenTM (using  ultrasound).  They
may  be  used  on  condition  that  the  interval  following  trauma
is  at  least  6  months  and  the  inter-fragment  gap  at  the  non-
union  site  is  less  than  10  mm.  They  represent  an  alternative
to  the  reference  attitude  of  corticocancellous  graft,  Judet
decortication  or  local  osteoinductive  injection  (bone  mor-
phogenetic  protein  or  bone-marrow  concentrate).
The  present  pilot  study  sought  to  assess  results  using
ExogenTM in  non-union  in  adults  and  the  limitations  of  the
technique.
Material and method
A  continuous  retrospective  study  was  conducted  in  the
Rouen  (France)  University  Hospital  Center  between  2004  and
2009.
The  external  stimulation  device  used  was  the  ExogenTM
system  (Smith  and  Nephew,  Memphis,  TN,  USA).  It  emits
low-frequency  (1.5  MHz)  ultrasound  with  a  1  kHz  repeti-
tion  module  creating  a  200  s signal  with  an  intensity  of
30  mW/cm2 (cf.  ultrasound  and  Doppler  medical  imaging
intensities  of  20  to  800  mW/cm2).  The  signal  induces  a nano-
movement  in  the  intercellular  matrix  at  the  non-union  site,
which  is  recognized  by  the  bone-cell  membrane  integrins.
At  cell  level,  the  signal  [2—5]  induces  synthesis  of  pro-
teins  involved  in  angiogenesis  (vascular  endothelial  growth
factor  [VEGF]),  osteogenesis  (osteocalcin),  bone  mine-
ralization  (alkaline  phosphatase),  matrix  (type-1  collagen
and  ﬁbronectin),  bone  consolidation  (prostaglandin  E2)  and
matrix  remodeling  (matrix  metalloproteinase  [MMP]).
The  inclusion  criteria  met  the  2002  Afssaps  (French  medi-
cal  product  safety  authority)  recommendations:  fracture
with  ﬁrst-line  surgery,  non-consolidated  at  6  months,  with
inter-fragment  gap  less  than  10  mm;  non-unions  secondary
to  osteotomy  or  arthrodesis  were  also  included.  Exclusion
F
briteria  were:  pregnancy,  congenital  non-union,  and  spine
r  skull  fracture.  During  the  period  2004  to  2009,  all  cases
f  non-union  meeting  these  inclusion  criteria  were  managed
sing  the  ExogenTM system.
Electromagnetic  ﬁeld  treatment  was  reserved  for  non-
nion  in  fracture  with  ﬁrst-line  conservative  management
mainly  clavicle  and  scaphoid  fracture).  Non-union  with
nter-fragment  gap  more  than  10  mm  was  managed  surgi-
ally.
Non-union  was  conﬁrmed  on  antero  posterior  (AP)  and
trict  lateral  X-ray  at  inclusion  by  the  absence  of  any  cor-
ical  or  cancellous  bone  bridge.  In  case  of  tight  non-union
r  bulky  osteosynthesis  material  hindering  cortical  analysis,
T  was  systematically  performed  to  check  absence  of  any
ontinuous  bridge  at  the  site.
Osteosynthesis  stability  was  assessed  at  inclusion,  based
n  clinical  and  radiological  data.  Stability  was  deﬁned  clini-
ally  as  absence  of  fracture  mobility  (frontal,  sagittal  origure  1  Ulnar  non-union,  osteosynthesis  considered  unsta-
le due  to  plate  rupture.
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Patient  data  on  smoking,  height  and  weight  were  col-
ected  and  body-mass  index  was  calculated.
To  position  the  transmitter,  an  AP  X-ray  view  of  the  non-
onsolidated  fracture  was  taken  and  a  radio-opaque  mark
as  made  on  the  skin  over  the  fracture  site,  which  was
sually  on  the  anterior  side  of  the  limb.  The  affected  bone
egment  was  not  immobilized,  with  motion  limited  only  by
riteria  of  pain.  Treatment  was  20  min  daily  until  consolida-
ion  or  a  maximum  of  6  months.  Patients  were  followed  up  at
 weeks,  and  3  and  6  months  after  initiation  of  stimulation.
P  and  lateral  X-rays  views  were  taken  at  each  consultation,
lus  CT  at  3  and  6  months.  At  each  consultation,  the  patient
as  asked  to  indicate  the  transmitter  site  and  compliance
as  checked  by  a  monitor  on  the  device,  which  showed  the
umber  of  treatment  cycles  the  patient  had  performed  at
ome.
Consolidation  was  checked  clinically  (absence  of  pain  on
xial  and  rotational  stress)  and  radiologically  on  plain  AP
nd  lateral  views  at  6  months  (continuity  of  at  least  three
orticals).  Radiological  consolidation  was  conﬁrmed  by  an
ndependent  investigator.
tatistics
tatistical  analysis  used  Fisher’s  exact  test  and  the  Mann-
hitney  test  for  medians.  It  was  performed  by  the
nstitution’s  biostatistics  department.
esults
etween  2004  and  2009,  60  cases  of  diaphyseal  or  meta-
hyseal  fracture  non-union  were  included:  38  males,  22
emales;  mean  age,  43  years  (range,  17—85  yrs).
Table  1  presents  the  bone  segments  and  types  of
steosynthesis.
One  patient  was  excluded  at  week  4  of  stimulation,  due
o  a  fractured  nail:  this  was  a  25-year-old  woman  with  bila-
eral  femoral  fracture  treated  by  nailing.  The  right  femur
ad  consolidated  in  4  months;  the  left  showed  atrophic
on-union,  subjected  to  ultrasound  after  500  days  (i.e.,
6  months).  Nailing  was  repeated,  and  consolidation  was
chieved  after  6  months.
d
d
s
d
Table  1  Distribution  of  non-union  according  to  bone  segment  an
Bone  segment  Number  of  cases  Nail  K-wire  
Humerus  6  3  1  
Ulna 4  0  1  
Radius 1  0  0  
Metacarpal  1  0  0  
Femur 12  6  0  
Tibia 24  7  0  
Fibula 4  0  1  
Tibiotalar arthrodesis  2  0  0  
Subtalar arthrodesis  1  1  0  
MP-hallux arthrodesis  1  0  0  
Metatarsal 3  0  1  
Toe phalanx  1  0  1  
MP: metatarso phalageal.X.  Roussignol  et  al.
Table  2  shows  data  for  the  remaining  59  patients:  gender,
ge,  bone  segment  concerned,  initial  treatment,  num-
er  and  type  of  surgical  procedures  for  non-union  prior
o  the  external  stimulation,  non-union  site  inter-fragment
ap,  osteosynthesis  stability,  interval  before  stimulation,
on-union  aspect,  smoking  status  (cigarettes/day)  and
onsolidation  at  6-month’  follow-up.
The  mean  interval  between  fracture  or  osteotomy  and
nitiation  of  ultrasound  stimulation  was  271  days  (range,  166
o  1394  days).  Mean  inter-fragment  gap  at  the  non-union  site
as  4  mm  (2—0  mm).  Non-union  was  atrophic  in  58  cases  and
ypertrophic  in  one  (Fig.  2).  In  ﬁve  cases,  osteosynthesis  was
onsidered  unstable  at  inclusion:
 one  diaphyseal  humeral  fracture  initially  treated  by  nail-
ing  and  simple  proximal  locking  with  more  than  45◦
rotational  motion  on  clinical  examination;
 one  ulnar  diaphysis  non-union  treated  by  plate  with  mobi-
lity  chamber  at  the  three  proximal  screws  of  the  plate;
 one  ulnar  diaphysis  non-union  associated  with  olecranon
fracture,  with  nail  retreat  and  defective  rig  tightening;
 one  tibial  non-union  treated  by  screwing;
 one  ﬁbular  non-union  with  broken  plate.
Mean  treatment  duration  was  151  days  (range,  90—240
ays).  There  were  no  locoregional  complications  related
o  device  positioning.  The  built-in  monitor  conﬁrmed  good
ompliance,  with  a  non-compliance  rate  of  less  than  5%  per
atient;  this  rate  did  not  correlate  with  treatment  failure.
The  6-month  consolidation  rate  following  external  sti-
ulation  was  88%  (seven  failures  out  of  59).
Statistically,  ﬁnal  consolidation  was  not  signiﬁcantly
elated  to  age  (P  =  0.68),  gender,  bone  segment  and  non-
nion  site,  BMI,  primary  osteosynthesis  type  (P  =  0.30),
moking  status  (P  =  0.38),  number  of  previous  procedures
P  =  0.15)  or  non-union  site  inter-fragment  gap  (P  =  0.62).
The  mean  interval  to  treatment  tended  to  differ  accor-
ing  to  consolidation  following  external  stimulation:  251
ays  in  the  group  showing  consolidation  at  follow-up,  ver-
us  420  days  in  the  group  comprising  the  seven  failures;  the
ifference,  however,  was  not  signiﬁcant  (P  =  0.06).
d  primary  surgery.
Screw  Plate  External  ﬁxator  Other
0  2  0  0
0  3  0  0
0  1  0  0
0  1  0  0
0  2  2  2  (cerclage)
3  2  12  0
0  1  0  2
2  0  0  0
0  0  0  0
1  0  0  0
2  0  0  0
0  0  0  0
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Table  2  Bone  segment  concerned  and  type  of  surgical  procedures.
Patient Sex  Age  Bone  segment  Primary  treatment  Procedures  Compl.  surgery  Gap  (mm)  Stability  Delay  Non-union  Smoking  Consolidation
1 M 30 Femur Nail 0 6 1 193 Atrophic 0 1
2  M  34  Femur  Nail  0  5  1  210  Atrophic  0  1
3 M  40  Tibia  External  ﬁxator  1  Graft  2  1  175  Atrophic  0  1
4 M 16  Humerus  Plate  0  3  1  166  Atrophic  10  1
5 F 54 Femur Nail 2 Nail  then  graft 6 1 1394 Atrophic 0 0
6 F 71 Humerus Nail 0 6 0 257 Atrophic 0 0
7 F 51 Tibia External  ﬁxator 0 4 1 514 Atrophic 15 1
8 M 21 Ulna Plate 0 3 0 291 Atrophic 0 0
9 F 48 Mandatarsal Screw 0 2 1 253 Atrophic 0 1
10 M 46 Ulna K-wire 1 CC  graft 5 0 300 Atrophic 6 0
11 M 43 Tibia Screw 1 4 0 394 Atrophic 0 1
12 F 80 Fibula Plate 0 3 1 200 Atrophic 0 1
13 F 30 Tibia External  ﬁxator 0 6 1 215 Atrophic 0 1
14 M 39 Tibia External  ﬁxator 0 5 1 190 Atrophic 0 1
15 F 85 Femur Nail 1 Nail  and  graft 7 1 210 Atrophic 0 1
16 M 29 Femur Nail 1 Nail  and  graft 6 1 245 Hypertrophic 0 1
17 F 26 Mandacarpal Plate 0 3 1 179 Atrophic 20 1
18 M 38 Tibia External  ﬁxator 0 6 1 185 Atrophic  15  1
19 M 35 Fibula Isolated  tibial  nail 1 Fibular  plate 4 0 249  Atrophic  20  1
20 M 41 Tibia Nail 0 5 1 230  Atrophic  0  1
21 F 23 Tibia Plate  for  osteotomy 0 5 1 184 Atrophic 0 1
22 M 28 Humerus Nail 0 3 1 456 Atrophic 0 1
23 M 37 Tibia External  ﬁxator 1 Secondary  nail 4 1 204 Atrophic 0 1
24 M 26 Tibia External  ﬁxator 0 5 1 183 Atrophic 10 1
25 M 46 Tibia Nail 0 4 1 190 Atrophic 0 1
26 F 17 Femur Plate 1 CC  graft 4 1 245 Atrophic 0 1
27 M 38 Ulna Plate 0 3 1 234 Atrophic 10 1
28 F 72 Femur femorotomy  cerclage 0 4 1 210 Atrophic 0 1
29 F 24 Humerus Nail 0 4 1 230 Atrophic 0 1
30 F 44 Mandatarsal Screw 0 3 1 183 Atrophic 0  1
31 M 18 Femur Nail 0 5 1 194 Atrophic 0 1
32 M 41 MP-hallux  arthrodesis Screw 0 2 1 190 Atrophic 0  1
33 M 27 Femur External  ﬁxator 1 CC  graft 10 1 720  Atrophic  20  1
34 M 50 Mandatarsal K-wire 0 2 1 185 Atrophic 0  1
35 M 55 Tibia External  ﬁxator 1 Plate  and  graft 4 1 360  Atrophic  30  1
36 M 57 Tibia External  ﬁxator 1 Plate  and  graft 3 1  550  Atrophic  20  1
37 M 61 Tibiotalar  arthrodesis Screw 1 CC  graft 4 1 440  atrophic  0  1
38 M 51 Toe phalanx K-wire 1 2 1 220  Atrophic  0  1
39 M 57 Tibiotalar  arthrodesis Screw 1 CC  graft 3  1  350  Atrophic  30  1
40 M 61 Femur Plate 1 Plate  3  1  190  Atrophic  0  1
41 F 61 Humerus K-wires 0 2 1  205  Atrophic  0  1
42 M 48 Humerus Plate 0 3  1  183  Atrophic  0  1
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There  was  a  signiﬁcant  relation  (P  =  0.01)  between  stable
steosynthesis  and  ﬁnal  consolidation.
The  group  of  seven  failures  comprised  one  femoral  shaft
on-union  with  nail  (stable  osteosynthesis,  but  pathological
MI  at  47);  four  non-unions  judged  unstable  at  inclusion;
ne  subtalar  non-union  with  primary  subchondral  strip-
ing  defect;  and  one  lateral  malleolar  non-union  (stable
steosynthesis  but  using  a  single  retrograde  nail).
iscussion
mmediate  post-traumatic  adjuvant  use  of  ultrasound  has
een  validated  in  several  studies.  Consolidation  time  in
ecent  fracture  was  reduced  by  about  30  to  40%  [1,6—9].
Application  in  non-union  was  ﬁrst  described  by  Xavier  and
uarte  [10,11]  in  1983,  with  a  70%  consolidation  rate  in  a
eries  of  28  cases.
In  1997,  Mayr  et  al.  [12], in  a  retrospective  series  of  877
ases  of  delayed  consolidation  divided  into  two  groups  (636
imple  delays,  treated  by  ExogenTM as  of  day  90  to  269  post-
rauma,  and  241  non-unions  with  treatment  initiated  as  of
ay  270  post-trauma),  reported  90%  consolidation  in  sim-
le  delay  and  85%  in  non-union.  Factors  for  poor  prognosis
or  bone  consolidation  were  renal  insufﬁciency,  arteritis  and
moking;  primary  osteosynthesis  stability  was  not  examined.
Rutten  et  al.  [13], in  a  series  of  71  lower-limb  fractures
ith  delayed  consolidation,  reported  a  73%  consolidation
ate,  but  did  not  analyze  causes  of  failure.
Nolte  et  al.  [14], in  2001,  reported  a  clinical  series  of  29
ases  of  non-union  treated  by  ultrasound.  Bone  segment  dis-
ribution  was  similar  to  that  in  the  present  series.  The  mean
nterval  between  initial  fracture  and  initiation  of  external
timulation  was  61  weeks  (i.e.,  15  months),  with  a  consoli-
ation  rate  of  86%.  Primary  osteosynthesis  stability  was  not
xamined.
Gebauer  et  al.  [15], in  2005,  in  a  series  of  67  cases  of
onsolidation  delay  exceeding  8  months,  reported  an  85%
onsolidation  rate.  Exclusion  criteria  were  contact  defect,
nstable  osteosynthesis  or  evolutive  sepsis.  As  in  the  present
eries,  external  therapy  was  shown  to  be  contra-indicated
n  case  of  unstable  osteosynthesis.
Schofer  et  al.  [16], in  2010,  published  a level-I  study  of
01  tibial  shaft  fractures  with  delayed  consolidation  at  4
onths  post-trauma,  comparing  the  ExogenTM device  versus
n  identical  but  inactive  device  case.  ExogenTM signiﬁcan-
ly  improved  bone  mineralization  (P  =  0.002)  and  reduced
racture  gap  (P  =  0.014).
The  present  88%  consolidation  rate  is  comparable  to
hose  of  recent  series.
Examining  patient  data,  neither  age  nor  gender  seemed
o  impact  the  success  of  external  stimulation.  Obesity  is  a
arameter  that  was  not  analyzed  in  previous  reports.  Ele-
ated  BMI  (>  40)  appeared  to  be  a  factor  of  failure,  taking
ccount  of  the  bone  site  and  adipose  tissue  thickness.  The
ransmitter  is  harder  for  the  patient  to  position  correctly  on
he  skin  over  the  fracture  site,  due  to  lack  of  subcutaneous
one  relief,  and  there  is  a  loss  of  signal  intensity,  due  to
iffusion,  at  the  non-union.  External  treatment  is  probably
ot  indicated  in  proximal  and  diaphyseal  femoral  non-union
n  case  of  BMI  more  than  40.
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Figure  2  Tibial  non-union  after  derotation  osteotomy  for  mal-union  following  nailing.  Postoperative  radiography:  radiograph
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In  the  present  series,  as  reported  by  Kyro  et  al.  [17],
smoking  did  not  correlate  with  failure  of  ExogenTM stimu-
lation.  The  overall  smoking  rate  was  28%,  with  11%  in  the
consolidation  group  and  14%  in  the  consolidation  failure
group.  The  inﬂuence  of  smoking  as  a  factor  in  non-union
consolidation  probably  becomes  negligible  next  to  local
post-traumatic  factors:  macro-mobility,  periosteal  lesion
and  muscle  mass  lesion.
The  present  series  was  too  small  to  analyze  the  inﬂu-
ence  of  non-union  site  on  consolidation.  This  parameter  was
assessed  by  Franckel  et  al.  [18]  in  a  registry  of  404  cases  of
delayed  consolidation:  consolidation  rates  were  70%  for  the
humerus,  86%  for  the  femur,  81%  for  the  metatarsals,  96%  for
the  scaphoid  and  83%  for  the  tibia.  Osteosynthesis  stability
according  to  surgical  site  and  intervals  to  treatment  were
not  analyzed.
The  interval  before  non-union  treatment  showed  a  trend
to  be  longer  in  the  external  stimulation  failure  group,
although  the  difference  was  not  signiﬁcant  (P  =  0.06).  Conso-
lidation  cannot  be  boosted  unless  callous  ossiﬁcation  is  still
ongoing.  Stromkvist  et  al.  [19]  showed  that  longstanding
non-union  no  longer  exhibited  ossiﬁcation  on  scintigraphy.
External  stimulation  has  to  be  initiated  at  an  early  stage,
before  the  callous  tissue  loses  its  ossiﬁcation  potential
(continuing  osteoblast  activity  at  the  site,  with  peripheral
hyperemia)  and  before  onset  of  synovial  non-union.
Rubin  et  al.  [20], in  a  registry  analysis,  conﬁrmed  the
impact  of  time  to  initiation  of  external  stimulation  the-
rapy:  success  rates  were  comparable  in  fracture  treated
between  days  91  and  150  (1790  fractures)  and  between  days
151  and  255  (1370  fractures),  at  91%  and  89%  respectively,
but  fell  to  83%  in  the  1540  fractures,  treated  later  than
day  255.  Six  months  would  seem  to  be  the  interval  after
which  consolidation  rates  with  external  stimulation  seem
to  diminish  —  and  unfortunately  corresponds  in  France  to
the  minimum  interval  required  for  national  health  insurance
coverage  of  the  treatment.  This  6-month  interval  require-
ment  and  the  restriction  of  external  stimulation  therapy  to
non-union  at  surgical  (fracture  or  osteotomy)  sites  are  spe-
TMciﬁc  to  France:  in  the  USA,  for  example,  Exogen has  Food
and  Drugs  Administration  (FDA)  approval  for  recent  fracture
and  for  delayed  consolidation  of  whatever  origin  (surgically
or  conservatively  managed  fracture  or  osteotomy).
c
p
pt  6  months  of  exogen  stimulation;  radiograph  at  12  weeks  of
A  long  interval  before  treatment  (exceeding  12  months
rom  trauma)  is  not  a  contra-indication  for  external  stimu-
ation:  the  consolidation  rate  with  ultrasound  in  such  cases
pproaches  60%  [9].  This  lower  success  rate  is  to  be  seen
gainst  the  technical  difﬁculty  and  complications  associated
ith  traditional  surgery  by  graft  or  decortication.
This  relation  between  ‘‘active’’  callous  tissue  and
esponse  to  ultrasound  was  also  found  in  hypertrophic  non-
nion.  Given  stable  osteosynthesis,  the  success  rate  for
xternal  stimulation  in  this  indication  approached  100%;  in
greement  with  Mayr  et  al.  [12,21,22], failure  in  the  present
eries  concerned  atrophic  non-union.
Osteosynthesis  stability  is  essential  to  consolidation.  In
greement  with  Gebauer  et  al.  [15], we  consider  non-
nion  showing  macro-mobility  due  to  material  (nail  or  plate)
reakage  or  to  deﬁcient  primary  osteosynthesis  rigidity  to
e  a  formal  contra-indication  to  external  stimulation  the-
apy.  Such  cases  should  be  managed  by  conventional  surgi-
al  revision  of  the  osteosynthesis  with  osteoinduction  at  the
on-union  site  (autograft,  Judet  decortication,  autologous
one  marrow  or  bone  morphogenetic  protein  injection).
In  non-union  with  stable  osteosynthesis,  the  ExogenTM
ystem  provides  an  alternative  to  osteoinduction-based  sur-
ical  procedures:
 cancellous  or  corticocancellous  graft;  Judet  decortication
(80%  mean  consolidation,  according  to  the  literature);
 Bone  Morphogenic  Protein  (BMP)  injection  (Friedlander
et  al.  [23]  reported  75%  consolidation);
 or  autologous  bone  marrow  injection  (Hernigou  et  al.  [24]
reported  71%  consolidation).
These  procedures  have  the  drawback  of  potential  comor-
idity  (graft  rejection,  anesthesia),  with  consolidation  rates
o  better  than  with  external  therapy.  They  may  be  indi-
ated  in  traumatology  for  bone  defects  of  10  to  40  mm  or
or  fracture  gaps  of  less  than  10  mm  if  the  osteosynthesis
eeds  revising  (material  breakage,  stability  defect,  etc.).
Fig.  3  presents  a  ﬂowchart  for  the  management  of
onsolidation  in  case  of  more  than  or  equal  to  6  months’
ostoperative  delay.
The  direct  competitor  of  the  ExogenTM system  is
ulsed  electromagnetic  ﬁeld  therapy.  In  France,  only  the
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hysioStimTM system  has  national  health  coverage  for  a
imilar  indication  (6-month  post-fracture  delay  in  conso-
idation,  inter-fragment  gap  inferior  to  10  mm).  The  one
ifference  is  the  possibility  of  treating  fractures  initially
anaged  conservatively.  PhysioStimTM is  applied  for  3  hours
er  day.  The  armband  emitting  the  electromagnetic  ﬁeld  is
ide  (increased  target  bone  area)  and  allows  application
t  the  root  of  the  limb.  Garland  et  al.  [25]  reported  75%
onsolidation  (181  patients  for  193  fractures),  and  found  no
orrelation  with  age,  gender,  age  of  non-union  or  fracture
ap  size;  osteosynthesis  stability  was  not  analyzed.  The  suc-
ess  rate  was  unaffected  by  previous  osteoinduction  surgery.
he  study,  however,  involved  several  biases,  with  23%  of
atients  not  adhering  to  a  minimal  12  weeks’  treatment,  and
ulticenter  data  collection  (74  institutions  for  181  patients:
.e.,  on  average,  less  than  three  patients  per  center).
Financially,  the  unit  cost  for  external  therapy  on
he  French  system  is  D  1772  —  much  less  than  for  the
‘decortication  with  or  without  complementary  osteosyn-
hesis’’  procedure  (coded  GHM  08c50),  which  is  invoiced
t  D  4480.22  (as  of  March  1st,  2011)  for  hospital  costs  for
 patient  free  of  comorbidity,  without  taking  account  of
ostoperative  home-care  costs  or  the  time  off  work  for  hos-
ital  admission.  The  ﬁnancial  advantage  of  external  therapy
as  conﬁrmed  by  Heckman  and  Kahn  [26], in  an  American
eries  of  tibial  fracture,  who  reported  overall  cost-saving  of
 13,000  to  $  15,000.
onclusion
he  present  series  conﬁrmed  the  literature  ﬁndings,  with
 consolidation  rate  of  80%.  Two  essential  criteria  are  to
e  considered  in  indicating  external  therapy:  non-union  site
nter-fragment  gap  less  than  10  mm,  and  stable  osteosynthe-
is.  The  ExogenTM stimulation  system  can  then  be  indicated
s  ﬁrst-line  treatment,  as  its  success  rate  is  better  thanatment  ﬂowchart.
ith  any  osteoinduction  surgery.  The  technique  is  non-
nvasive,  and  should  be  implemented  early,  as  of  6-month
ost-trauma.  Cost  saving  for  society,  using  external  therapy
ather  than  a  classical  surgical  procedure  such  as  grafting,
ay  be  estimated  at  between  D  2000  and  D  8000.
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